Development of a core outcome set for multimorbidity trials in low/middle-income countries (COSMOS): study protocol

Jan R Boehnke^{1

2}, Rusham Zahra Rana³, Jamie J Kirkham⁴, Louise Rose⁵, Gina Agarwal⁶, Corrado Barbui^{7

8}, Alyssa Chase-Vilchez⁹, Rachel Churchill¹⁰, Oscar Flores-Flores^{11

12}, John R Hurst¹³, Naomi Levitt¹⁴, Josefien van Olmen¹⁵, Marianna Purgato^{7

8}, Kamran Siddiqi^{2

16}, Eleonora Uphoff¹⁰, Rajesh Vedanthan¹⁷, Judy Wright¹⁸, Kath Wright¹⁹, Gerardo A Zavala², Najma Siddiqi^{2

16}

Affiliations

¹ School of Health Sciences, University of Dundee, Dundee, UK j.r.boehnke@dundee.ac.uk.
² Department of Health Sciences, University of York, York, UK.
³ Institute of Psychiatry, Rawalpindi Medical University, Rawalpindi, Pakistan.
⁴ Centre for Biostatistics, The University of Manchester, Manchester, UK.
⁵ Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK.
⁶ Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.
⁷ WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
⁸ Cochrane Global Mental Health, University of Verona, Verona, Italy.
⁹ Global Alliance for Chronic Diseases, London, UK.
¹⁰ Centre for Reviews and Dissemination and Cochrane Common Mental Disorders, University of York, York, UK.
¹¹ Facultad de Medicina Humana, Centro de Investigación del Envejecimiento (CIEN), Universidad San Martin de Porres, Lima, Peru.
¹² Asociación Benéfica PRISMA, Lima, Peru.
¹³ UCL Respiratory, University College London, London, UK.
¹⁴ Chronic Disease Initiative for Africa and Division of Endocrinology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
¹⁵ Department of Family Medicine and Population Health, University of Antwerp, Antwerpen, Belgium.
¹⁶ Hull York Medical School, York, UK.
¹⁷ Department of Population Health, NYU Grossman School of Medicine, New York University, New York, New York, USA.
¹⁸ Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
¹⁹ Centre for Reviews and Dissemination, University of York, York, UK.

PMID: 35172996
PMCID: PMC8852662
DOI: 10.1136/bmjopen-2021-051810

Development of a core outcome set for multimorbidity trials in low/middle-income countries (COSMOS): study protocol

Jan R Boehnke et al. BMJ Open. 2022.

. 2022 Feb 16;12(2):e051810.

doi: 10.1136/bmjopen-2021-051810.

Authors

Affiliations

¹ School of Health Sciences, University of Dundee, Dundee, UK j.r.boehnke@dundee.ac.uk.
² Department of Health Sciences, University of York, York, UK.
³ Institute of Psychiatry, Rawalpindi Medical University, Rawalpindi, Pakistan.
⁴ Centre for Biostatistics, The University of Manchester, Manchester, UK.
⁵ Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK.
⁶ Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.
⁷ WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation Department of Neurosciences, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
⁸ Cochrane Global Mental Health, University of Verona, Verona, Italy.
⁹ Global Alliance for Chronic Diseases, London, UK.
¹⁰ Centre for Reviews and Dissemination and Cochrane Common Mental Disorders, University of York, York, UK.
¹¹ Facultad de Medicina Humana, Centro de Investigación del Envejecimiento (CIEN), Universidad San Martin de Porres, Lima, Peru.
¹² Asociación Benéfica PRISMA, Lima, Peru.
¹³ UCL Respiratory, University College London, London, UK.
¹⁴ Chronic Disease Initiative for Africa and Division of Endocrinology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
¹⁵ Department of Family Medicine and Population Health, University of Antwerp, Antwerpen, Belgium.
¹⁶ Hull York Medical School, York, UK.
¹⁷ Department of Population Health, NYU Grossman School of Medicine, New York University, New York, New York, USA.
¹⁸ Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
¹⁹ Centre for Reviews and Dissemination, University of York, York, UK.

PMID: 35172996
PMCID: PMC8852662
DOI: 10.1136/bmjopen-2021-051810

Abstract

Introduction: 'Multimorbidity' describes the presence of two or more long-term conditions, which can include communicable, non-communicable diseases, and mental disorders. The rising global burden from multimorbidity is well documented, but trial evidence for effective interventions in low-/middle-income countries (LMICs) is limited. Selection of appropriate outcomes is fundamental to trial design to ensure cross-study comparability, but there is currently no agreement on a core outcome set (COS) to include in trials investigating multimorbidity specifically in LMICs. Our aim is to develop international consensus on two COSs for trials of interventions to prevent and treat multimorbidity in LMIC settings.

Methods and analysis: Following methods recommended by the Core Outcome Measures in Effectiveness Trials initiative, the development of these two COSs will occur in parallel in three stages: (1) generation of a long list of potential outcomes for inclusion; (2) two-round online Delphi surveys and (3) consensus meetings. First, to generate an initial list of outcomes, we will conduct a systematic review of multimorbidity intervention and prevention trials and interviews with people living with multimorbidity and their caregivers in LMICs. Outcomes will be classified using an outcome taxonomy. Two-round Delphi surveys will be used to elicit importance scores for these outcomes from people living with multimorbidity, caregivers, healthcare professionals, policy makers and researchers in LMICs. Finally, consensus meetings including all of these stakeholders will be held to agree outcomes for inclusion in the two COSs.

Ethics and dissemination: The study has been approved by the Research Governance Committee of the Department of Health Sciences, University of York, UK (HSRGC/2020/409/D:COSMOS). Each participating country/research group will obtain local ethics board approval. Informed consent will be obtained from all participants. We will disseminate findings through peer-reviewed open access publications, and presentations at global conferences selected to reach a wide range of LMIC stakeholders.

Prospero registation number: CRD42020197293.

Keywords: clinical trials; protocols & guidelines; quality in health care; statistics & research methods.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

1. Murray CJL, Barber RM, Foreman KJ, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. The Lancet 2015;386:2145–91. 10.1016/S0140-6736(15)61340-X - DOI - PMC - PubMed
1. Pati S, Swain S, Knottnerus JA, et al. Magnitude and determinants of multimorbidity and health care utilization among patients attending public versus private primary care: a cross-sectional study from Odisha, India. Int J Equity Health 2020;19:57. 10.1186/s12939-020-01170-y - DOI - PMC - PubMed
1. Palladino R, Tayu Lee J, Ashworth M, et al. Associations between multimorbidity, healthcare utilisation and health status: evidence from 16 European countries. Age Ageing 2016;45:431–5. 10.1093/ageing/afw044 - DOI - PMC - PubMed
1. Mai Q, Holman C D'Arcy J, Sanfilippo FM, et al. The impact of mental illness on potentially preventable hospitalisations: a population-based cohort study. BMC Psychiatry 2011;11:163. 10.1186/1471-244X-11-163 - DOI - PMC - PubMed
1. Barra M, Augestad LA, Whitehurst DGT, et al. Examining the relationship between health-related quality of life and increasing numbers of diagnoses. Qual Life Res 2015;24:2823–32. 10.1007/s11136-015-1026-3 - DOI - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Development of a core outcome set for multimorbidity trials in low/middle-income countries (COSMOS): study protocol

Affiliations

Development of a core outcome set for multimorbidity trials in low/middle-income countries (COSMOS): study protocol

Authors

Affiliations

Abstract

Conflict of interest statement

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources